PHARMECO aims to trigger
a green revolution in the manufacture of medicines

The health sector has a significant impact on the environment; in OECD (Organisation for Economic 
Co-operation and Development) countries, it is responsible for between 3 and 8% of CO2 emissions. It also uses large quantities of water, energy, solvents and fossil-based raw materials, and generates a lot of waste.

PHARMECO will accelerate the adoption of sustainable practices across the pharmaceutical sector, driving measurable improvements in environmental performance and contributing to global climate goals​.

Health-sector-emits-CO2-PHARMECO-promotes-sustainability
PHARMECO-develops-sustainable-pharma-tools.

PHARMECO will address the production of small molecules, tides, and biologics, medical devices & technologies, with a key focus on:

  • Sustainable-by-Design (SSbD) platforms for early-stage pharmaceutical development
  • Green processes for industrial-scale manufacturing and decontamination
  • Advanced digital tools for sustainability assessment and decision-making

PHARMECO plans to harmonise the way sustainability assessments of pharmaceuticals are carried out, by delivering guidelines that are scientifically-robust, practical, and accepted by all stakeholders.

Together, the project outputs will form a comprehensive toolkit to support the development and manufacture of more sustainable pharmaceuticals and to evaluate their environmental impact along the whole life cycle.

PHARMECO anticipated long-term impacts

PHARMECO-anticipated-long-term-impacts

PHARMECO’s structure

PHARMECO-s-structure

Key figures

calendrier

72

months
euro

45M€

investment
earth

14

countries
partners

31

partners

A public-private partnership
of
31 international organisations

Coordinated by Ghent University
(Centre of Excellence for Sustainable Pharmaceutical Enginering and Manufacturing)

Seeking for more information?